Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. OptiBiotix Health Share Price
  4. OptiBiotix Health Share News
  5. OptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiary

Pin to quick picksOptiBiotix Health Share News (OPTI)

OptiBiotix Health Information

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.00 (5.714%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiary

Tue, 21st Feb 2023 14:15

(Alliance News) - OptiBiotix Health PLC on Tuesday said that Rene Kamminga, Chief Executive Officer of subsidiary OptiBiotix Ltd, will leave the business next week Tuesday.

The York, England-based probiotics developer tackling obesity, cardiovascular diseases and lifestyle conditions announced it appointed its CEO Stephen O'Hara as CEO of the subsidiary.

O'Hara "will lead a minor restructuring of the business," OptiBiotix added.

Optibiotix shares were 2.8% lower at 12.89 pence each in London on Tuesday afternoon.

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
19 Jan 2021 16:30

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

Read more
11 Jan 2021 17:29

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

Read more
5 Jan 2021 17:55

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

Read more
9 Dec 2020 16:08

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

Read more
18 Nov 2020 14:53

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

Read more
18 Nov 2020 12:23

OptiBiotix grants LPLDL licence to Canada's Genuine Health

(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary ProBiotix Health has granted a non-exclusive licence for 'LPLDL' to Genuine Health, for a cardiovascular health product in Canada and the United States.

Read more
12 Oct 2020 14:34

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

Read more
12 Oct 2020 14:00

OptiBiotix products launch into retail in Australia, New Zealand

(Sharecast News) - Life sciences company OptiBiotix Health announced the launch of meal replacement shakes and bars containing its 'OptiBiome' proprietary weight management technology under the 'Optislim' brand with the Woolworths and Chemist Warehouse retailers, and online, in Australia and New Zealand.

Read more
8 Oct 2020 21:16

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float

Read more
6 Oct 2020 14:36

IN BRIEF: OptiBiotix's ProBiotix Inks Singaporean Deal For CholBiomeX3

IN BRIEF: OptiBiotix's ProBiotix Inks Singaporean Deal For CholBiomeX3

Read more
2 Oct 2020 11:13

OptiBiotix Notes FDA Approval For Investigation Into Partner's New Drug

OptiBiotix Notes FDA Approval For Investigation Into Partner's New Drug

Read more
2 Oct 2020 10:17

OptiBiotix shares rise as partner Seed gets FDA approval

(Sharecast News) - Life sciences company OptiBiotix Health announced on Friday that one of its partners, Seed Health, has received US Food and Drug Administration authorisation for an investigational new drug (IND) application for 'DS-01'.

Read more
24 Sep 2020 12:25

OptiBiotix revenue improves fivefold in first half

(Sharecast News) - Life sciences company OptiBiotix Health reported first-half revenue growth to £0.74m in its first half on Thursday, which was a five times increase in revenues from the first half of 2019.

Read more
24 Sep 2020 12:04

IN BRIEF: OptiBiotix Pretax Loss Narrows, Prepares For Dual Listing

IN BRIEF: OptiBiotix Pretax Loss Narrows, Prepares For Dual Listing

Read more
22 Sep 2020 15:04

IN BRIEF: OptiBiotix Inks SlimBiome License Deal With HiLife Vitamins

IN BRIEF: OptiBiotix Inks SlimBiome License Deal With HiLife Vitamins

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.